Compare WHLR & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WHLR | GCTK |
|---|---|---|
| Founded | 2011 | 2001 |
| Country | United States | United States |
| Employees | 49 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5M | 1.4M |
| IPO Year | N/A | 2011 |
| Metric | WHLR | GCTK |
|---|---|---|
| Price | $1.82 | $0.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 234.7K | ★ 3.8M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 31.22 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.01 | $0.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.65 | $0.09 |
| 52 Week High | $10.05 | $15.90 |
| Indicator | WHLR | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 60.78 | 44.93 |
| Support Level | $1.55 | $0.64 |
| Resistance Level | $2.44 | $1.02 |
| Average True Range (ATR) | 0.27 | 0.13 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 61.17 | 23.08 |
Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Cypress Shopping Center in Boiling Springs, South Carolina, and others.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.